This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
IVP to approve Q2 and H1 FY2026-27 results on November 4
IVP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 1.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
IVP Limited will meet its board on November 4, 2026 to approve unaudited results and a limited review report for the quarter and half year ended September 30, 2026. The trading window remains closed until 48 hours after the results are announced.
The filing sets the results date but provides no figures or performance details, so no direct earnings impact can be assessed.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹171.7 Cr | ₹147.0 Cr | +16.8% |
| Operating profit | ₹5.38 Cr | ₹4.41 Cr | +22.0% |
| Profit after tax | ₹4.65 Cr | ₹4.00 Cr | +16.3% |
| EBITDA margin | 5.1% | 5.5% | −0.5 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.